ReviewFrontiers in oncology2025

Mapping the clinical trial landscape of multiple primary lung cancer in the era of precision oncology: persistent exclusion and design limitations hamper evidence-based treatment development.

Jianwei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.